TAMs from human neoplasms express arginase1, IL10, and transforming growth factor beta (TGFβ); these cytokines reduce the anti-tumor activity of T cells and natural killer cells and modulate tumor proliferation, infiltration, and angiogenesis [1]. This evidence concerns the gene TGFB1 and neoplasm.